239 related articles for article (PubMed ID: 21734186)
1. Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.
Kotlo KU; Hesabi B; Danziger RS
Am J Physiol Cell Physiol; 2011 Oct; 301(4):C929-37. PubMed ID: 21734186
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.
Piggott LA; Hassell KA; Berkova Z; Morris AP; Silberbach M; Rich TC
J Gen Physiol; 2006 Jul; 128(1):3-14. PubMed ID: 16769793
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle.
Hamad AM; Range S; Holland E; Knox AJ
Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous nuclear ribonucleoprotein A1 is a novel cellular target of atrial natriuretic peptide signaling in renal epithelial cells.
Hesabi B; Danziger RS; Kotlo KU
Cell Signal; 2012 May; 24(5):1100-8. PubMed ID: 22285803
[TBL] [Abstract][Full Text] [Related]
6. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
Wong JC; Fiscus RR
J Cell Biochem; 2011 Mar; 112(3):829-39. PubMed ID: 21328456
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide attenuates the expression of natriuretic peptide receptor C and associated adenylyl cyclase signaling in aortic vascular smooth muscle cells: role of MAPK.
Arejian M; Li Y; Anand-Srivastava MB
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1859-67. PubMed ID: 19252090
[TBL] [Abstract][Full Text] [Related]
9. Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells.
Sharma GD; Nguyen HT; Antonov AS; Gerrity RG; von Geldern T; Pandey KN
Mol Cell Biochem; 2002 Apr; 233(1-2):165-73. PubMed ID: 12083372
[TBL] [Abstract][Full Text] [Related]
10. ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells.
Li P; Oparil S; Novak L; Cao X; Shi W; Lucas J; Chen YF
J Appl Physiol (1985); 2007 Jan; 102(1):390-8. PubMed ID: 17038494
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase.
Lincoln TM; Wu X; Sellak H; Dey N; Choi CS
Front Biosci; 2006 Jan; 11():356-67. PubMed ID: 16146737
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle.
Hamad AM; Johnson SR; Knox AJ
Am J Physiol; 1999 Nov; 277(5):L910-8. PubMed ID: 10564175
[TBL] [Abstract][Full Text] [Related]
15. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase.
Kumar R; Cartledge WA; Lincoln TM; Pandey KN
Hypertension; 1997 Jan; 29(1 Pt 2):414-21. PubMed ID: 9039136
[TBL] [Abstract][Full Text] [Related]
16. IRAG determines nitric oxide- and atrial natriuretic peptide-mediated smooth muscle relaxation.
Desch M; Sigl K; Hieke B; Salb K; Kees F; Bernhard D; Jochim A; Spiessberger B; Höcherl K; Feil R; Feil S; Lukowski R; Wegener JW; Hofmann F; Schlossmann J
Cardiovasc Res; 2010 Jun; 86(3):496-505. PubMed ID: 20080989
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC; Challiss RA; Boyle JP
Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
[TBL] [Abstract][Full Text] [Related]
18. Preincubation with atrial natriuretic peptide protects NG108-15 cells against the toxic/proapoptotic effects of the nitric oxide donor S-nitroso- N-acetylpenicillamine.
Cheng Chew SB; Leung PY; Fiscus RR
Histochem Cell Biol; 2003 Sep; 120(3):163-71. PubMed ID: 14504961
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production.
Vandenwijngaert S; Ledsky CD; Agha O; Wu C; Hu D; Bagchi A; Domian IJ; Buys ES; Newton-Cheh C; Bloch DB
PLoS One; 2018; 13(4):e0196697. PubMed ID: 29698509
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet-derived growth factor receptor tyrosine kinase by atrial natriuretic peptide.
Awazu M
Kidney Int; 1997 Aug; 52(2):356-62. PubMed ID: 9263990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
